Healthcare & Life Sciences Insights
Discover Latham’s latest insights into the commercial, regulatory, and legal developments shaping the global healthcare and life sciences landscape.
Trending Topics
Featured Insights
Our Work
Latham Advises Canaan and Brandon Capital on Pathios’ US$25 Million Series B
Latham & Watkins Advises Endeavor BioMedicines on US$132.5 Million Oversubscribed Series C Financing
Recognition
Twelve Latham Partners Ranked Among Top Lawyers in EMEA
MergerLinks recognized the firm’s M&A work across multiple areas including healthcare and life sciences, technology, and antitrust.
Latham Named Life Sciences Practice Group of the Year
Firm recognized by Law360 for major court victories and high-profile deals.
M&A and Private Equity Practice Tops 2023 Year-End League Tables
Latham’s #1 rankings reinforce firm’s position as a global transactional powerhouse.